Akebia Therapeutics
AKBA
#6737
Rank
C$0.69 B
Marketcap
$2.65
Share price
-2.59%
Change (1 day)
31.44%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.86

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.90. In 2022 the company made an earnings per share (EPS) of -$0.72 an increase over its 2021 EPS that were of -$2.39.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.8620.39%
2022-$0.72-70%
2021-$2.39-38.63%
2020-$3.9017.37%
2019-$3.322.79%
2018-$3.2331.2%
2017-$2.47-51.39%
2016-$5.0757.89%
2015-$3.21-94.83%
2014-$62.14589.75%
2013-$9.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.93-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.27-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$19.84-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.30 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA